Ching-Wen Chang

1PUBLICATIONS
2CO-AUTHORS
Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jul 27, 2022
A Newly Engineered A549 Cell Line Expressing ACE2 and TMPRSS2 Is Highly Permissive to SARS-CoV-2, Including the Delta and Omicron Variants.

Ching-Wen Chang, Krishna Mohan Parsi, Mohan Somasundaran

Pageof 1

Frequent Collaborators

1 joint publications

Krishna Mohan Parsi

1 joint publications

Ping Liu